Triple-negative breast cancer (TNBC) is characterized by the limited expression of the human epidermal growth factor receptor 2 (HER2), estrogen receptor (ER), and progesterone receptor (PR) and accounts for approximately 15 % of invasive breast cancers. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.